[1]
“METABOLIC SYNDROME IN MADHUMEGAM (TYPE 2 DIABETES MELLITUS) PATIENTS REPORTING AT NATIONAL INSTITUTE OF SIDDHA – A CROSS SECTIONAL STUDY”, Int J Ayu Pharm Res, vol. 7, no. 8, pp. 35–40, Oct. 2019, Accessed: Dec. 28, 2025. [Online]. Available: https://www.ijapr.in/index.php/ijapr/article/view/1276